| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||
- | - | - | - | 338 | 516 | 1,449 | 279 | 125 |
Revenues from related parties | ||||||||
- | - | - | - | - | 6 | 108 | 3 | 12 |
Revenues | ||||||||
10,765 | 5,660 | 2,739 | 994 | - | 523 | 1,558 | 282 | - |
Cost of revenue | ||||||||
4,383 | 2,626 | 1,384 | 1,226 | 1,224 | 1,197 | 404 | 265 | 641 |
Gross profit | ||||||||
6,382 | 3,033 | 1,355 | -232 | -885 | -674 | 1,154 | 16 | -503 |
Operating expenses: | ||||||||
Selling and marketing | ||||||||
4,583 | 2,462 | 1,421 | 713 | 884 | 1,537 | 301 | - | - |
Research and development | ||||||||
701 | 194 | 181 | 343 | 375 | 610 | 56 | - | - |
General and administrative | ||||||||
8,914 | 4,950 | 4,271 | 2,568 | 4,633 | 6,455 | 3,243 | 904 | 810 |
Impairment of related party non-marketable securities | ||||||||
- | - | - | 50 | 0 | - | - | - | - |
Amortization and depreciation | ||||||||
- | - | - | 570 | 534 | 416 | 359 | 149 | - |
Total operating expenses | ||||||||
14,199 | 7,607 | 5,873 | 4,246 | 6,428 | 9,019 | 3,960 | 1,053 | - |
Patent impairment expense | ||||||||
- | - | - | - | - | - | - | - | 147 |
Operating loss | ||||||||
-7,817 | -4,573 | -4,518 | -4,478 | -7,313 | -9,694 | -2,806 | -1,036 | -1,461 |
Other income (expense): | ||||||||
Other income | ||||||||
12 | 0 | - | - | - | - | - | - | - |
Change in fair value of warrant liability | ||||||||
-98 | 0 | - | - | - | - | - | - | - |
Unrealized loss on derivative liabilities | ||||||||
- | - | -155 | -2,758 | 187 | 0 | - | - | - |
Realized loss on marketable securities | ||||||||
- | - | - | - | - | - | -19 | 12 | - |
Unrealized gain (loss) on marketable securities | ||||||||
-0 | -0 | -0 | -2 | -10 | -10 | - | - | -3 |
Loss on settlement of debt | ||||||||
0 | -267 | -15 | -1,664 | 0 | - | - | - | - |
Other income | ||||||||
- | - | - | 0 | 3 | 0 | - | - | - |
Loss on conversion of accounts receivable to marketable securities | ||||||||
- | - | - | - | - | 36 | - | - | - |
Interest income (expense), net | ||||||||
-75 | -178 | -917 | -675 | -76 | -10 | - | - | - |
Interest expense - related party | ||||||||
- | - | - | - | - | 0 | 56 | 141 | 280 |
Total other (loss) income | ||||||||
34 | -446 | -1,089 | -5,100 | 104 | -56 | -76 | -129 | -283 |
Net loss | ||||||||
-7,783 | -5,019 | -5,607 | -9,578 | -7,209 | -9,750 | -2,882 | -1,166 | -1,744 |
Deemed dividend on Series A Convertible preferred stock | ||||||||
- | - | - | - | 594 | 0 | - | - | - |
Dividends on Series A Convertible preferred stock | ||||||||
52 | 53 | 75 | 80 | 58 | 0 | - | - | - |
Net loss available to common stockholders | ||||||||
-7,835 | -5,073 | -5,683 | -9,658 | -7,862 | -9,750 | - | - | - |
Net loss per common share-basic and diluted | ||||||||
-0.97 | -0.74 | -1.21 | -2.44 | -0.10 | -0.16 | -0.07 | -0.04 | -0.06 |
Weighted average common shares outstanding-basic and diluted | ||||||||
8,107 | 6,892 | 4,693 | 3,956 | 80,445 | 61,962 | 42,514 | 30,161 | 30,005 |